3 Canadian Biotechs to Consider Buying Today
Innovation knows no borders allowing adventurous biotech investors the opportunity to find hidden gems located outside the major research and development hubs in the U.S., Europe, and Japan. One doesn't even need to look too far.
Here we preview three such companies hailing from Canada, specifically the greater Vancouver area, which boast promising drugs in their pipelines and just raised additional financing from savvy insitutional investors eager to get ahead of the curve. These emerging biotechs may be the ticket for risk-tolerant investors to boost their portfolios.
Image source: Getty Images.
Source Fool.com
